“I switched to DOVATO because it has just 2 medicines in 1 pill.”
Lucciano
Beach Lover
Switched to DOVATO
The DOVATO difference
DOVATO is a once-a-day complete treatment that is designed differently because it delivers powerful results* with fewer medicines.
Take DOVATO exactly as your healthcare provider tells you.
No other complete HIV pill contains fewer medicines than DOVATO.
Unlike most HIV treatments that have 3 or 4 medicines, DOVATO has just 2 medicines in 1 pill.
DOVATO is as effective at helping you stay undetectable with fewer medicines* in your body—today and tomorrow.
Results may vary.
*Based on data from the GEMINI 1 & 2 studies (patients new to treatment) and TANGO study (patients replacing their current HIV treatment). DOVATO was compared with a regimen containing either 3 or 4 medicines, measuring either the percentage of patients with an undetectable viral load (<50 copies per mL) or the percentage of patients without an undetectable viral load (≥50 copies per mL).
Aging with HIV
Ann, Robin, and Morgan share how HIV treatment has changed over the years, and why fewer medicines was appealing to them in making the switch to DOVATO.
How do I take DOVATO?
Once a day
Any time of day, around
the same time of day
With or without food
What do the studies say?
If you are considering switching treatment or are new to treatment, DOVATO is clinically proven to be as effective as a regimen containing 3 or 4 medicines. See details below.
Proven effective in people already on HIV treatment
In the TANGO study, DOVATO was proven to help people already on treatment stay undetectable as effectively as an HIV regimen containing 3 or 4 medicines.†
- The majority of patients taking DOVATO or a 3- or 4-drug regimen† remained undetectable over a 3-year period.
- 1% or less had a detectable viral load (50 or more copies per mL) with DOVATO or a 3- or 4-drug regimen† at 1 year. Similar results were seen at 3 years.
- 0 adults who switched to DOVATO developed resistance through 3 years in clinical trials.
- Results showed that DOVATO works in a diverse group of adults, regardless of age, sex, race, or CD4 T-cell count.
Side effects
In the TANGO study, 15% of patients taking DOVATO versus 5% taking a 3- or 4-drug regimen† experienced side effects over a 3-year period. The majority of side effects were mild in severity.
The most common side effects reported by patients taking DOVATO over a 3-year period were weight gain (3%), trouble sleeping (2%), nausea (1%), diarrhea (1%), and anxiety (1%).
The most common side effects reported by patients taking a 3- or 4-drug regimen† over a 3-year period were weight gain (2%), nausea (<1%), diarrhea (<1%), and anxiety (<1%).
Tenofovir alafenamide–based (TAF) 3- or 4-drug regimen.
Proven effective in people new to HIV treatment
In the GEMINI studies, DOVATO was proven to help people new to treatment reach and stay undetectable (less than 50 copies per mL) as effectively as a regimen containing 3 medicines.‡
- The majority of people were undetectable at 1 year, which was maintained through 3 years.
Side effects
Across the combined GEMINI studies, 20% of patients taking DOVATO versus 27% taking a 3-drug regimen‡ experienced side effects over a 3-year period.
The most common side effects reported by patients taking DOVATO over a 3-year period were headache (3%), nausea (2%), diarrhea (2%), trouble sleeping (2%), tiredness (2%), anxiety (2%), and dizziness (1%).
The most common side effects reported by patients taking a 3-drug regimen‡ over a 3-year period were headache (4%), nausea (6%), diarrhea (3%), trouble sleeping (3%), tiredness (2%), anxiety (1%), and dizziness (2%).
Dolutegravir + tenofovir disoproxil fumarate/emtricitabine.
“When I found out I may be able to stay undetectable with fewer medicines, I talked to my doctor about switching to DOVATO.”
Results may vary.
Jovon
Nature Lover
Switched to DOVATO
Hear from real people on DOVATO.
Learn why they made the switch.
What should I ask my doctor about DOVATO?
Here’s a helpful guide for talking with your doctor.
DLLWCNT220029
